Granulomatosis Polyangiitis (GPA) Samples
Granulomatosis with polyangiitis (GPA), a condition once known as Wegener’s granulomatosis, is a rare autoimmune disease that inflames the body’s small and medium-sized blood vessels.
Worldwide, it is estimated to affect roughly 10 to 20 people per million each year.
Because the disease can damage the lungs and kidneys quickly, researchers depend on carefully collected Granulomatosis with Polyangiitis Samples to understand why the immune system turns against the body and how to treat it more safely.
At Bay Biosciences, we understand this need and provide high-quality human biospecimens that support vasculitis and autoimmune research.
These include Granulomatosis with Polyangiitis Blood Samples, GPA Serum Samples, GPA Plasma Samples, and other ANCA-Associated Vasculitis Samples.
Understanding Granulomatosis with Polyangiitis
GPA belongs to a group of conditions called ANCA-associated vasculitis, which also includes microscopic polyangiitis and eosinophilic granulomatosis with polyangiitis.
What sets GPA apart is a combination of granulomas, which are small clusters of inflamed immune cells, and damage to the walls of small and medium vessels.
The upper airways, lungs, and kidneys are the most common targets.
The key players are antibodies. In most patients, the immune system makes antineutrophil cytoplasmic antibodies, or ANCA, that attack a protein called proteinase 3 (PR3). These PR3-ANCA are found in about 75 to 90% of GPA cases.
This antibody-driven process is why Autoimmune Vasculitis Samples matter so much for research, and why Vasculitis Research Samples often include serum and plasma that can be tested for these antibodies.
Symptoms of Granulomatosis with Polyangiitis
Many patients first notice problems in areas such as the nose, sinuses, or chest.
Sinus pain, cough, and nasal congestion are common early complaints, which is why the disease is often mistaken for an ordinary infection.
Other signs include:
- Bloody nasal discharge, nasal ulcers, nasal congestion, and a persistent cough, sometimes with coughed-up blood or chest pain, as well as shortness of breath
- Fever, fatigue, unexplained weight loss, and aching joints or muscles
- Kidney involvement, which may show up as blood in the urine or protein in the urine
When the kidneys are affected, the damage can progress quickly, and some patients need dialysis.
Because these symptoms overlap with many other conditions, doctors rely on laboratory and tissue testing before they reach a diagnosis.
Causes and Risk Factors of Granulomatosis with Polyangiitis
Doctors still do not know exactly what sets GPA in motion.
Current evidence points to a mix of environmental, genetic, and infectious influences, although the reasons the body produces so much ANCA remain unclear.
Researchers are therefore studying the immune system, genes, and past infections together rather than looking for a single trigger.
Diagnosis of Granulomatosis with Polyangiitis
No single test settles the question. Doctors weigh the symptoms, imaging, and blood results together, and a biopsy usually helps support the conclusion.
A blood test for ANCA is central, because PR3-ANCA is highly specific for GPA and appears in about 90% of patients with widespread disease. A negative result, however, does not rule the diagnosis out.
Doctors also order blood tests such as CRP, ESR, and creatinine, plus a urine test, to check for inflammation and kidney injury.
CT scans of the chest and sinuses often reveal nodules or masses, and these can sometimes look like lung cancer.
A kidney or lung biopsy then confirms the pattern. Importantly, treatment should not wait for the biopsy when suspicion is high, since delay can be dangerous.
Treatment of Granulomatosis with Polyangiitis
Treatment is divided into two stages: bringing the disease under control, and then keeping it there.
In the first stage, patients usually receive high-dose glucocorticoids combined with either rituximab or cyclophosphamide.
Rituximab, which removes B cells, has proved useful for both inducing and maintaining remission, and trials have shown that steroid doses can be cut well below older levels without losing effectiveness.
Long-term use of corticosteroids is still a concern because of side effects.
A newer option is avacopan, an oral drug that blocks the C5a receptor.
It lets doctors lower steroid exposure, and in the ADVOCATE trial, it was linked to better sustained remission and kidney recovery than a steroid taper.
For severe relapses, plasma exchange may also be considered.
Even so, relapses are common once maintenance treatment stops, so researchers continue to look for markers that can predict who needs longer therapy. Studies of Human Blood Samples over time are central to that effort.
Applications of Granulomatosis with Polyangiitis Samples for Research
Serum and plasma are the most informative samples for GPA. Human Serum Samples and Human Plasma Samples let researchers measure ANCA levels, cytokines, and complement proteins.
Samples collected before, during, and after treatment add another layer. Rituximab clears CD20-positive B cells but not long-lived plasma cells, which may keep making ANCA.
Paired samples from the same patient help scientists study why some people relapse while others stay in remission. They also help test whether biomarkers can guide maintenance better than fixed schedules.
GPA also shares features with other immune-mediated diseases. By comparing it with Autoimmune Disease Samples and other Inflammatory Disease Samples, researchers can separate what is unique to ANCA vasculitis from what is shared across conditions.
Frequently Asked Questions
What are Granulomatosis with Polyangiitis Samples used for?
Researchers use them to study ANCA biology, search for biomarkers of disease activity and relapse, and test new diagnostic assays. They also support drug discovery and translational research on vasculitis.
Can researchers compare GPA samples with healthy controls?
Yes. Researchers can compare disease samples with normal healthy donor samples to find differences in antibodies, cytokines, and other biomarkers.
Are Bay Biosciences’ human biospecimens ethically sourced?
Yes. We collect all human samples through appropriate consent and IRB-approved protocols.
Supporting Your Research with Bay Biosciences
At Bay Biosciences, we provide human biospecimens to pharmaceutical companies, biotechnology organizations, academic institutions, and diagnostic developers.
Our comprehensive range of samples includes:
- Granulomatosis with Polyangiitis Samples
- ANCA-Associated Vasculitis Samples
- Autoimmune Vasculitis Samples
- Giant Cell Arteritis (GCA) Samples
- Polyarteritis Nodosa Samples
- Autoimmune Disease Samples
- Inflammatory Disease Samples
- Human serum samples
- Human plasma samples
- Peripheral blood mononuclear cells (PBMCs)
- Human blood samples
- Normal healthy donor samples
If you have any questions, concerns, or special requests, please don’t hesitate to reach out to us! Our team is always happy to help.